+43 664 883 16206
marion.ettenauer@orthosera.com
Orthopedics
Novel serum – based therapies
for the regeneration of bone and joints
Dentistry
Serum – enhanced human allograft
the next generation of bone fillers
Dermatology
Innovative serum
for rejuvenation

Our Products

BoneAlbumin™

BoneAlbumin™

Human bone allograft impregnated with serum albumin. This patented technology offers excellent bone remodeling by attracting and activating the...

Learn more
hypACT™ inject

hypACT™ inject

An innovative serum derivative that outperforms PRP at regeneration of cells and tissues.

Learn more

Who We Are?

OrthoSera is a regenerative medicine company harnessing the power of blood serum for human diseases. Our R&D is currently focused on bone grafting, osteoarthritis, wound healing, as well as dental and orthopedic indications. Blood serum has a high regenerative potential and based on this fact OrthoSera has already developed two technologies.

BoneAlbumin is essentially a serum albumin enhanced bone allograft that was shown to activate bone marrow stem cells leading to faster and better bone healing. This tissue product is already in commercial stage with two double-blind clinical studies proving its effectiveness in sports surgery and dentistry. Our next technology takes this concept even further, as we use a proprietary method to isolate a specific, growth-factor rich serum fraction (hyperacute serum or hypACTTM) that has shown superior effects in promoting cell proliferation in osteoarthritic bone, cartilage, and mesenchymal stem cells among others.

Hyperacute serum is also patent-covered and can be applied at the bedside with our CE-marked medical device, hypACT inject.

What We Do?

Dermatology
Orthopedics
Dentistry
From the Blog

Learn About Our Leading Technologies

OrthoSera closes Series B financing round

hypACT™ serum therapy for the regeneration of osteoarthritic bone and cartilage is entering clinical development Krems an der Donau, Austria, 09 February 2017 –...

Read more

OrthoSera Receives CE Mark for hypACT™ Device to Regenerate Osteoarthritic Bone

Krems an der Donau, Austria, September 07, 2016 / B3C newswire / — OrthoSera GmbH, an orthobiologics company developing serum-based solutions for...

Read more

BoneAlbumin induces better bone formation

Krems an der Donau, Austria, 29 June 2016 – OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications announces that...

Read more
Contact Us

Your request answered within 24 hours